Microsatellite instability, promoter methylation and protein expression of the DNA mismatch repair genes in epithelial ovarian cancer

Genomics

Volumn 104, Issue 4, 2014, Pages 257-263

  Shilpa, V ^a   Bhagat, Rahul ^a   C S , Premalata ^a   V R , Pallavi ^a   Krishnamoorthy, Lakshmi ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

LOH; MMR; MSI; Ovarian cancer; Promoter methylation

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; MICROSATELLITE DNA; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MIDDLE AGED; MISMATCH REPAIR; MLH1 GENE; MSH2 GENE; OVARY CARCINOMA; PMS2 GENE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; YOUNG ADULT; CARCINOMA; GENETICS; GENOMIC INSTABILITY; METABOLISM; OVARY TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; CARCINOMA; DNA METHYLATION; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; GENOMIC INSTABILITY; HUMANS; MICROSATELLITE REPEATS; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC;

EID: 84908175980     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2014.08.016     Document Type: Article

References (44)

1. Rebecca S., Deepa N., Ahmedin J. Cancer statistics 2013. CA Cancer J. Clin. 2013, 63:11-30.
2. Sasiadek M.M., Stembalska-Kozlowska A., Smigiel R., et al. Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. BJC 2004, 90:1594-1599.
3. Herman J.G., Merlo A., Mao L., et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995, 55:4525-4530.
4. Jiricny Y., Nystrom-Lahti M. Mismatch repair defects in cancer. Curr. Opin. Genet. Dev. 2000, 10:157-161.
5. Hayashi M., Tamura G., Jin Z., et al. Microsatellite instability in esophageal squamous cell carcinoma is not associated with hMLH1 promoter hypermethylation. Pathol. Int. 2003, 53:270-276.
6. Olga S.K., Pawel S., Malgorzata W.D., et al. Immunohistochemical analysis of hMLH1 and hMSH2 proteins in serous ovarian tumors. Pol. J. Pathol. 2009, 4:174-178.
7. Laghi L., Bianchi P., Malesci A. Differences and evolution of the methods for the assessment of microsatellite instability. Oncogene 2008, 27:6313-6321.
8. Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993, 260:816-819.
9. Codegoni A.M., Bertoni F., Colella G., et al. Microsatellite instability and frameshift mutations in genes involved in cell cycle progression or apoptosis in ovarian cancer. Oncol. Res. 1999, 11:297-301.
10. Johannsdottir J.T., Jonasson J.G., Bergthorsson J.T., et al. The effect of mismatch repair deficiency on tumorigenesis: microsatellite instability affecting genes containing short repeated sequences. Int. J. Oncol. 2000, 16:133-139.
11. Caliman L.P., Tavares R.L., Piedade J.B., et al. Evaluation of microsatellite instability in women with epithelial ovarian cancer. Oncol. Lett. 2012, 4(3):556-560.
12. Pal T., Permuth-Wey J., Sellers T.A. A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer. Cancer 2008, 113:733-742.
13. Bacani J., Zwingerman R., Di Nicola N., et al. Tumor microsatellite instability in early onset gastric cancer. J. Mol. Diagn. 2005, 7:465-477.
14. Plisiecka-Hałasa J., Dansonka-Mieszkowska A., Kraszewska E., et al. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas. Anticancer Res. 2008, 28:989-996.
15. Shen X.J., Ali-Fehmi R., Weng C.R., et al. Loss of heterozygosity and microsatellite instability at the Xq28 and the A/G heterozygosity of the QM gene are associated with ovarian cancer. Cancer Biol. Ther. 2006, 5:523-528.
16. Megan A.M., Nicolas W. Frequency of mismatch repair deficiency in ovarian cancer: a systematic review. Int. J. Cancer 2011, 129(8):1914-1922.
17. Gras E., Catasus L., Arguelles R., et al. Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer 2001, 92:2829-2836.
18. Loukola A., Eklin K., Laiho P., et al. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res. 2001, 61:4545-4549.
19. Sood A.K., Holmes R., Hendrix M.J., et al. Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer. Cancer Res. 2001, 61:4371-4374.
20. Lu Y., Liu X.S., Wang Y.X., et al. Study of microsatellite instability in epithelial ovarian tumors. Beijing Da Xue Xue Bao 2006, 38:62-65.
21. Yoon B.S., Kim Y.T., Kim J.H., et al. Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors. Yonsei Med. J. 2008, 49:272-278.
22. Chaves P., Cruz C., Lage P., et al. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J. Pathol. 2000, 191:355-360.
23. Lindor N.M., Burgart L.J., Leontovich O., et al. Immunohistochemistry vs microsatellite instability testing in phenotyping colorectal tumors. J. Clin. Oncol. 2002, 20:1043-1048.
24. Cai K.Q., Albarracin C., Rosen D., et al. Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Hum. Pathol. 2004, 35:552-559.
25. Allen H.J., DiCioccio R.A., Hohmann P., et al. Microsatellite instability in ovarian, other pelvic carcinomas. Cancer Genet. Cytogenet. 2000, 117(2):163-166.
26. Pyatt R., Chadwick R.B., Johnson C.K., et al. Polymorphic variation at the BAT-25 and BAT-26 loci in individuals of African origin. Implications for microsatellite instability testing. Am. J. Pathol. 1999, 155:349-353.
27. Liu J., Albarracin C.T., Chang K.H., et al. Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer. Mod. Pathol. 2004, 17:75-80.
28. Demokan S., Suoglu Y., Demir D., et al. Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer. Ann. Oncol. 2006, 17:995-999.
29. Gray I.C., Campbell D.A., Spurr N.K. Single nucleotide polymorphisms as tools in human genetics. Hum. Mol. Genet. 2000, 9:2403-2408.
30. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997, 57:808-811.
31. Geisler J.P., Goodheart M.J., Sood A.K., et al. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer 2003, 98:2091-2094.
32. Murata H., Khattar N.H., Kang Y., et al. Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability. Oncogene 2002, 21:5696-5703.
33. Esteller M., Catasus L., Matias-Guiu X., et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am. J. Pathol. 1999, 155:1767-1772.
34. de La Chapelle A. Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry? The jury is still out. J. Clin. Oncol. 2002, 20:897-899.
35. Diniz G., Aktas S., Cubuk C., et al. Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases. Pediatr. Hematol. Oncol. 2013, 30(4):273-284.
36. Terdiman J.P., Gum J.R., Conrad P.G., et al. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 2001, 120:21-30.
37. Schweizer P., Moisio A.L., Kuismanen S.A., et al. Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer. Cancer Res. 2001, 61:2813-2815.
38. Lynch H.T. Hereditary nonpolyposis colorectal cancer (HNPCC). Cytogenet. Cell Genet. 1999, 86:130-135.
39. Loeb K.R., Loeb L.A. Significance of multiple mutations in cancer. Carcinogenesis 2000, 21:379-385.
40. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998, 58:5248-5257.
41. Upama L.W., Takayuki N., Hironobu K., et al. Infrequent microsatellite instability in liver fluke infection associated intrahepatic cholangiocarcinomas from Thailand. Int. J. Cancer 2003, 107:375-380.
42. Daniel G.R., Kathy Q.C., Rajyalakshmi L., et al. Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma. Mod. Pathol. 2006, 19:1414-1420.
43. Gongyuan Z., Qiuliang L., Chunxiao M., et al. Genic expression and promoter methylation of hMSH2 in esophageal cancer tissues. Life Sci. J. 2008, 5(4):23-27.
44. Watanabe Y., Koi M., Hemmi H., et al. A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer. BJC 2001, 85(7):1064-1069.